Rugby Natural Iron Supplement Recall: Bottles May Contain Wrong Pills

|
Irvin Jackson

Add Your Comments

A recall has been issued for Rugby Natural Iron Supplement tablets, after a pharmacist found the wrong drugs inside of a bottle. 

The Rugby Natural Iron Supplement recall was announced by the FDA on January 17, after at least one complaint was received by the manufacturer, Advance Pharmaceutical Inc., indicating that a bottle was filled with Meclizine tablets, which are sold under the brand names Dramamine, Bonine, Postafen, Sea Legs, Meclozine and Antivert. There have been no adverse events or injuries reported in connection with the recall.

Rugby Natural Iron Supplements are ferrous sulfate tablets, but the tablets found inside the bottle, Meclizine HCI 25 mg, could cause serious side effects to those taking sedatives or consuming alcohol, as well as to those with a pre-existing CNS disorder, those who have kidney or liver problems, and could also harm the elderly or infants nursing on mothers who were given the drugs immediately after childbirth.

Do You Know about…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION
Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Do You Know About…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION

Meclizine is an antihistamine usually prescribed to treat nausea, motion sickness and some forms of vertigo. The iron supplement pills are designed to be taken three times daily, and taking the Meclizine three times a day would put the consumer near the maximum daily dose of 100 mg. It is a long-acting drug that builds up inside the body and whose affects could last up to 24 hours. Other side effects can include impaired alertness, drowsiness, confusion, low blood pressure, coma, and respiratory depression. The FDA and Advance Pharmaceutical warn that toxicity from the drug could build to life-threatening levels.

The recall affects Ferrous Sulfate Tablets, 325 mg, with a lot number of 12G468, and an expiration date of 07/14. They were sold under the Rugby Natural Iron Supplement label and have a UPC barcode of 0 0536-5890-01 3. The recalled lot was sold in 100 count bottles.

Consumers with questions or who have an affected lot can contact Advance Pharmaceutical with questions at (631) 981-4600, ext. 300.

Irvin Jackson
Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Tags: Dietary Supplement, Medication Error
Image Credit: |

More Lawsuit Stories

0 Comments

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Bard PowerPort Lawyers Make Final Preparations for Next MDL Bellwether Trial
Plaintiffs and defendants have submitted a joint schedule for a final pretrial conference before the second Bard PowerPort lawsuit bellwether trial over claims the port catheter is defectively designed.
Boston Scientific Spinal Cord Stimulator Lawyers To Meet With MDL Judge for Initial Conference Aug. 5
A federal judge appointed to oversee all federally consolidated Boston Scientific spinal cord stimulator lawsuits has called for an initial scheduling conference in early August.
Breast Reconstruction Mesh Market Expands Despite Lawsuits Over Synthetic Mesh Failures
Analysts expect wider use of breast reconstruction mesh through 2030, even as lawsuits raise questions about synthetic products, FDA approval and serious complications requiring additional surgery.